{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:32:16Z","timestamp":1759530736836,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jneuroim.2015.10.010","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T23:29:39Z","timestamp":1445729379000},"page":"84-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis"],"prefix":"10.1016","volume":"289","author":[{"given":"Colin","family":"Casault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayoun","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelan","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.10.010_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1528-1167.2009.02287.x","article-title":"Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody","volume":"51","author":"Barajas","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0010","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/01.wnl.0000276946.08412.ef","article-title":"Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy","volume":"69","author":"Bien","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0015","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/brain\/aws082","article-title":"Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis","volume":"135","author":"Bien","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2014.03.012","article-title":"Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis","volume":"271","author":"Brown","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0025","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0030","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0035","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in broadening phenotype","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/RLU.0b013e318286b58b","article-title":"18F-FDG PET\/CT findings in voltage-gated potassium channel limbic encephalitis","volume":"38","author":"Kamaleshwaran","year":"2013","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-014-7408-6","article-title":"Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity","author":"Malter","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0055","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","article-title":"Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors","volume":"33","author":"Ohkawa","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0060","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(14)60684-X","article-title":"Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies","volume":"383","author":"Sen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0070","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1212\/WNL.0b013e318239c3d7","article-title":"Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?","volume":"77","author":"Striano","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0075","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.05.048","article-title":"Natural course of LGI1 encephalitis: 3\u20135years follow-up without immunotherapy","volume":"343","author":"Szots","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2015.10.010_bb0080","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/jnnp.2009.178293","article-title":"An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis","volume":"81","author":"Wong","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:26:15Z","timestamp":1759047975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815300564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":16,"alternative-id":["S0165572815300564"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2015 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}